Logo - springer
Slogan - springer

Biomedical Sciences - Immunology | Autoimmunity Highlights

Autoimmunity Highlights

Autoimmunity Highlights

Editor-in-Chief: NICOLA BIZZARO

ISSN: 2038-0305 (print version)
ISSN: 2038-3274 (electronic version)

Journal no. 13317

PB_Banner_Open_Access_13317_ani_575x60
  • Presents material of interest to diverse professionals working on autoimmune diseases
  • Examines all aspects of autoimmune diseases, including diagnosis, treatment and management
  • Offers specific coverage of Rheumatoid arthritis, Coeliac disease, autoimmune thyroid disease, Diabetes and more

Autoimmunity Highlights publishes papers related to the diverse aspects of autoimmunity, bridging the interests of the clinic, the laboratory and specialists involved in the complex world of autoimmunity diagnosis.

This international journal focuses on pathogenesis, immunology, genetics, molecular biology, diagnostic auto-antibody tests, epidemiology, pathophysiology and the treatment of autoimmune diseases. New challenges in the field receive special attention, among them genetics, molecular biology, genomics and proteomics, point-of-care testing (POCT), information technology and communication (ITC) and health economics.

The range of disorders covered is comprehensive, encompassing Connective tissue diseases; Rheumatoid arthritis; Antiphospholipid syndrome; Coeliac disease; Gastrointestinal autoimmune diseases; Vasculitis; Autoimmune thyroid diseases, diabetes, endocrine diseases, liver diseases and skin diseases; Neurologic autoimmunity; POCT, EBM, ITC and health economics; and more.

Related subjects » Immunology

Abstracted/Indexed in 

SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, OCLC, SCImago, Summon by ProQuest

Popular Content within this publication 

 

Articles

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Autoimmunity Highlights publishes papers related to the diverse aspects of autoimmunity, a bridge between the clinic, the laboratory and the specialists who are involved in the complex world of autoimmunity diagnosis.

    Autoimmunity Highlights focuses on pathogenesis, immunology, genetics, molecular biology, diagnostic auto-antibody tests, epidemiology, pathophysiology and the treatment of autoimmune diseases.

    Special, but not exclusive, attention will be given to new challenges such as genetics, molecular biology, genomics and proteomics, point-of-care testing (POCT), information technology and communication (ITC) and health economics.

    The journal will deal with several areas of clinical interest, such as connective tissue diseases, rheumatoid arthritis, antiphospholipid syndrome, coeliac disease, gastrointestinal autoimmune diseases, vasculitis, autoimmune thyroid diseases, autoimmune diabetes, autoimmune endocrine diseases, autoimmune liver diseases, autoimmune skin diseases, neurologic autoimmunity, POCT, EBM, ITC and health economics, new technologies.

    Reports will be published in the form of original articles, short communications, case reports, letters to the editor and congress news. Invited reviews, editorials and new techniques of innovative importance in the field of autoimmunity will also be published. An international perspective on autoimmunity guidelines will also be welcome.

  • Submit Online
  • Instructions for Authors

    Instructions for Authors

    Close

  • Compliance with Ethical Requirements
  • Author Academy: Training for Authors
  • Copyright information

    Copyright information

    Close

    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.


    © Springer-Verlag Italia

Alerts for this journal

 

Get the table of contents of every new issue published in Autoimmunity Highlights.